PUBLISHER: Acute Market Reports | PRODUCT CODE: 1486526
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1486526
Digital Therapeutics Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032
The digital therapeutics market is expected to witness a CAGR of 32.1% during the forecast period of 2024 to 2032, driven by the increasing burden of chronic diseases, the imperative to curb rising healthcare costs and ongoing technological advancements. However, regulatory challenges pose a notable restraint, necessitating collaborative efforts for streamlined validation processes. Market segmentation reveals distinct trends in application focus, end-use preferences, and sales channel dynamics. Preventive applications are poised for significant growth, indicating a shift towards proactive healthcare management. Payers play a pivotal role in revenue generation, while employers emerge as a segment with high growth potential. B2C channels are expected to experience substantial growth, reflecting direct engagement between providers and end-users.
Key Market Drivers
Increasing Chronic Disease Burden
One of the primary drivers propelling the digital therapeutics market is the escalating burden of chronic diseases worldwide. Conditions such as diabetes, cardiovascular diseases, and mental health disorders have witnessed a surge, necessitating effective and accessible therapeutic interventions. Digital therapeutics offer a promising solution, providing patients with convenient, technology-driven tools to manage and mitigate the impact of chronic ailments. Evidence suggests a growing acceptance and adoption of these digital solutions, with patients benefitting from personalized and remote care options, ultimately contributing to improved health outcomes.
Rise in Healthcare Costs
The rising costs associated with traditional healthcare models have prompted a shift towards more cost-effective and efficient alternatives, driving the demand for digital therapeutics. With a focus on preventive care and treatment management, these solutions offer a cost-efficient approach to healthcare delivery. Evidence indicates that digital therapeutics can lead to reduced hospitalizations, lower medication costs, and overall healthcare expenditure. The emphasis on value-based care and the potential for long-term cost savings are key factors driving the integration of digital therapeutics into healthcare ecosystems.
Technological Advancements and Connectivity
Advancements in technology, particularly in the realms of mobile health (mHealth) and wearable devices, are instrumental in the growth of digital therapeutics. The widespread availability of smartphones and connected devices has facilitated the seamless delivery of therapeutic interventions to patients. Evidence showcases the positive impact of remote monitoring, real-time data collection, and personalized treatment plans enabled by technological innovations. The convergence of healthcare and digital technology creates opportunities for enhanced patient engagement and adherence to treatment regimens, contributing to the overall effectiveness of digital therapeutics.
Restraint
Regulatory Challenges and Validation: Despite the positive momentum, the digital therapeutics market faces challenges related to regulatory frameworks and the need for robust validation processes. Ensuring the safety, efficacy, and quality of digital therapeutic interventions requires navigating complex regulatory landscapes globally. Evidence suggests instances where uncertainties in regulatory pathways have hindered the rapid deployment of digital therapeutics. Addressing these challenges necessitates collaboration between industry stakeholders and regulatory bodies to establish clear guidelines and validation standards, fostering a conducive environment for market growth.
Market Segmentation Analysis
By Application: Treatment/Care-related Applications Dominate the Market
The market is segmented based on application categories, including Preventive Applications and Treatment/Care-related Applications. In 2023, the highest revenue was generated from Treatment/Care-related Applications, reflecting the growing adoption of digital therapeutics as complementary tools in the treatment landscape. However, the segment with the highest Compound Annual Growth Rate (CAGR) during the forecast period of 2024 to 2032 is expected to be Preventive Applications, indicating a shift towards proactive healthcare management and preventive interventions.
By End-use: Payers Dominate the Market
Another crucial segmentation is based on end-use categories, including Patients, Providers, Payers, Employers, and Others. In 2023, the highest revenue was attributed to Payers, emphasizing the role of insurance providers and healthcare payers in driving the adoption of digital therapeutics. However, the segment with the highest CAGR during the forecast period is expected to be Employers, highlighting the increasing focus on employee well-being and corporate wellness programs.
By Sales Channel: B2B channels Dominate the Market
The market is further segmented by sales channels, including B2C (Patients and Caregivers) and B2B (Providers, Payers, Employers, Pharmaceutical Companies, and Other Buyers). In 2023, the highest revenue was generated from B2B channels, showcasing the significance of institutional adoption and partnerships. However, the segment with the highest CAGR during the forecast period is expected to be B2C, indicating a growing trend of direct engagement between digital therapeutics providers and end-users.
North America Leads in Revenue and CAGR
Geographically, North America leads in both revenue and CAGR, with a well-established healthcare ecosystem and early adoption of digital therapeutics. The Asia-Pacific region presents a high CAGR, driven by increasing healthcare investments and a growing awareness of digital health solutions. Competitive trends highlight the pivotal roles played by key players, including Pear Therapeutics, Omada Health, and Akili Interactive, each contributing to the market's dynamism with unique strategies. As the market progresses from 2024 to 2032, stakeholders can anticipate a vibrant landscape marked by innovation, strategic collaborations, and the continued integration of digital therapeutics into mainstream healthcare practices.
Market Competition to Intensify during the Forecast Period
In the realm of digital therapeutics, key players such as Pear Therapeutics, Omada Health, Akili Interactive, Welldoc, Inc., 2Morrow, Inc, Livongo Health, Inc. (Teladoc Health, Inc.), Propeller Health (ResMed), Fitbit LLC, Mango Health, Canary Health, Noom, Inc., Hygieia, DarioHealth Corp., BigHealth, Gaia AG, and Limbix Health, Inc. have emerged as frontrunners, each adopting distinct strategies to navigate the evolving market. Pear Therapeutics focuses on developing prescription-based digital therapeutics, including reSET and reSET-O for substance use disorder. Omada Health specializes in digital care programs, addressing conditions like diabetes and obesity. Akili Interactive, known for its video game-based therapeutic platform, EndeavorRx, targets pediatric attention deficit hyperactivity disorder (ADHD). These companies are expected to play pivotal roles from 2024 to 2032, with their 2023 revenues reflecting past successes and strategies geared toward anticipated growth.
Historical & Forecast Period
This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Digital Therapeutics market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Digital Therapeutics market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.
Market Segmentation
Application
- Preventive Applications
- Prediabetes
- Obesity
- Nutrition
- Lifestyle Management
- Other Preventive Applications
- Treatment/Care-related Applications
- Diabetes
- CNS Disorders
Mental Health Disorder
Other CNS Disorders
- Chronic Respiratory Disorders
- Musculoskeletal Disorders
- Cardiovascular Diseases
- Smoking Cessation
- Medication Adherence
- Gastrointestinal Disorders
- Substance Use & Addiction Management
- Rehabilitation & Patient Care
- Other Treatment/Care-related Applications
Sales Channel
- B2C
- Patients
- Caregivers
- B2B
- Providers
- Payers
- Employers
- Pharmaceutical Companies
- Other Buyers
End-Use
- Patients
- Providers
- Payers
- Employers
- Others
Region Segment (2022-2032; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Digital Therapeutics market?
What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2032.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Digital Therapeutics market?
Which is the largest regional market for Digital Therapeutics market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Digital Therapeutics market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Digital Therapeutics market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Digital Therapeutics Market
- 2.2. Global Digital Therapeutics Market, By Application, 2023 (US$ Million)
- 2.3. Global Digital Therapeutics Market, By Sales Channel, 2023 (US$ Million)
- 2.4. Global Digital Therapeutics Market, By End-Use, 2023 (US$ Million)
- 2.5. Global Digital Therapeutics Market, By Geography, 2023 (US$ Million)
- 2.6. Attractive Investment Proposition by Geography, 2023
3. Digital Therapeutics Market: Competitive Analysis
- 3.1. Market Positioning of Key Digital Therapeutics Market Vendors
- 3.2. Strategies Adopted by Digital Therapeutics Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2023 Versus 2032
4. Digital Therapeutics Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Digital Therapeutics Market Value, 2022 - 2032, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
- 4.6. Porter's Five Force Model
- 4.6.1. Supplier Power
- 4.6.2. Buyer Power
- 4.6.3. Threat Of Substitutes
- 4.6.4. Threat Of New Entrants
- 4.6.5. Competitive Rivalry
- 4.7. PESTEL Analysis
- 4.7.1. Political Landscape
- 4.7.2. Economic Landscape
- 4.7.3. Technology Landscape
- 4.7.4. Legal Landscape
- 4.7.5. Social Landscape
5. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2023 Versus 2032
- 5.3. Market Segmentation
- 5.3.1. Preventive Applications
- 5.3.1.1. Prediabetes
- 5.3.1.2. Obesity
- 5.3.1.3. Nutrition
- 5.3.1.4. Lifestyle Management
- 5.3.1.5. Other Preventive Applications
- 5.3.2. Treatment/Care-related Applications
- 5.3.2.1. Diabetes
- 5.3.2.2. CNS Disorders
- 5.3.2.2.1. Mental Health Disorder
- 5.3.2.2.2. Other CNS Disorders
- 5.3.2.3. Chronic Respiratory Disorders
- 5.3.2.4. Musculoskeletal Disorders
- 5.3.2.5. Cardiovascular Diseases
- 5.3.2.6. Smoking Cessation
- 5.3.2.7. Medication Adherence
- 5.3.2.8. Gastrointestinal Disorders
- 5.3.2.9. Substance Use & Addiction Management
- 5.3.2.10. Rehabilitation & Patient Care
- 5.3.2.11. Other Treatment/Care-related Applications
- 5.3.1. Preventive Applications
6. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2023 Versus 2032
- 6.3. Market Segmentation
- 6.3.1. B2C
- 6.3.2. Patients
- 6.3.3. Caregivers
- 6.3.4. B2B
- 6.3.5. Providers
- 6.3.6. Payers
- 6.3.7. Employers
- 6.3.8. Pharmaceutical Companies
- 6.3.9. Other Buyers
7. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 7.1. Market Overview
- 7.2. Growth & Revenue Analysis: 2023 Versus 2032
- 7.3. Market Segmentation
- 7.3.1. Patients
- 7.3.2. Providers
- 7.3.3. Payers
- 7.3.4. Employers
- 7.3.5. Others
8. North America Digital Therapeutics Market, 2022-2032, USD (Million)
- 8.1. Market Overview
- 8.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 8.3. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 8.4. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 8.5.Digital Therapeutics Market: By Region, 2022-2032, USD (Million)
- 8.5.1.North America
- 8.5.1.1. U.S.
- 8.5.1.1.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 8.5.1.1.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 8.5.1.1.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 8.5.1.2. Canada
- 8.5.1.2.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 8.5.1.2.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 8.5.1.2.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 8.5.1.3. Rest of North America
- 8.5.1.3.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 8.5.1.3.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 8.5.1.3.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 8.5.1.1. U.S.
- 8.5.1.North America
9. UK and European Union Digital Therapeutics Market, 2022-2032, USD (Million)
- 9.1. Market Overview
- 9.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 9.3. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 9.4. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 9.5.Digital Therapeutics Market: By Region, 2022-2032, USD (Million)
- 9.5.1.UK and European Union
- 9.5.1.1. UK
- 9.5.1.1.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 9.5.1.1.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 9.5.1.1.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 9.5.1.2. Germany
- 9.5.1.2.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 9.5.1.2.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 9.5.1.2.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 9.5.1.3. Spain
- 9.5.1.3.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 9.5.1.3.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 9.5.1.3.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 9.5.1.4. Italy
- 9.5.1.4.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 9.5.1.4.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 9.5.1.4.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 9.5.1.5. France
- 9.5.1.5.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 9.5.1.5.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 9.5.1.5.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 9.5.1.6. Rest of Europe
- 9.5.1.6.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 9.5.1.6.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 9.5.1.6.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 9.5.1.1. UK
- 9.5.1.UK and European Union
10. Asia Pacific Digital Therapeutics Market, 2022-2032, USD (Million)
- 10.1. Market Overview
- 10.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 10.3. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 10.4. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 10.5.Digital Therapeutics Market: By Region, 2022-2032, USD (Million)
- 10.5.1.Asia Pacific
- 10.5.1.1. China
- 10.5.1.1.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 10.5.1.1.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 10.5.1.1.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 10.5.1.2. Japan
- 10.5.1.2.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 10.5.1.2.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 10.5.1.2.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 10.5.1.3. India
- 10.5.1.3.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 10.5.1.3.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 10.5.1.3.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 10.5.1.4. Australia
- 10.5.1.4.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 10.5.1.4.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 10.5.1.4.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 10.5.1.5. South Korea
- 10.5.1.5.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 10.5.1.5.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 10.5.1.5.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 10.5.1.6. Rest of Asia Pacific
- 10.5.1.6.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 10.5.1.6.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 10.5.1.6.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 10.5.1.1. China
- 10.5.1.Asia Pacific
11. Latin America Digital Therapeutics Market, 2022-2032, USD (Million)
- 11.1. Market Overview
- 11.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 11.3. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 11.4. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 11.5.Digital Therapeutics Market: By Region, 2022-2032, USD (Million)
- 11.5.1.Latin America
- 11.5.1.1. Brazil
- 11.5.1.1.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 11.5.1.1.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 11.5.1.1.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 11.5.1.2. Mexico
- 11.5.1.2.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 11.5.1.2.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 11.5.1.2.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 11.5.1.3. Rest of Latin America
- 11.5.1.3.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 11.5.1.3.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 11.5.1.3.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 11.5.1.1. Brazil
- 11.5.1.Latin America
12. Middle East and Africa Digital Therapeutics Market, 2022-2032, USD (Million)
- 12.1. Market Overview
- 12.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 12.3. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 12.4. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 12.5.Digital Therapeutics Market: By Region, 2022-2032, USD (Million)
- 12.5.1.Middle East and Africa
- 12.5.1.1. GCC
- 12.5.1.1.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 12.5.1.1.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 12.5.1.1.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 12.5.1.2. Africa
- 12.5.1.2.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 12.5.1.2.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 12.5.1.2.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 12.5.1.3. Rest of Middle East and Africa
- 12.5.1.3.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
- 12.5.1.3.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
- 12.5.1.3.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
- 12.5.1.1. GCC
- 12.5.1.Middle East and Africa
13. Company Profile
- 13.1. Pear Therapeutics
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
- 13.2. Omada Health
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
- 13.3. Akili Interactive
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
- 13.4. Welldoc, Inc.
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
- 13.5. 2Morrow, Inc
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
- 13.6. Livongo Health, Inc. (Teladoc Health, Inc.)
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
- 13.7. Propeller Health (ResMed)
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
- 13.8. Fitbit LLC
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
- 13.9. Mango Health
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
- 13.10. Canary Health
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
- 13.11. Noom, Inc.
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives
- 13.12. Hygieia
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Portfolio
- 13.12.4. Strategic Initiatives
- 13.13. DarioHealth Corp.
- 13.13.1. Company Overview
- 13.13.2. Financial Performance
- 13.13.3. Product Portfolio
- 13.13.4. Strategic Initiatives
- 13.14. BigHealth
- 13.14.1. Company Overview
- 13.14.2. Financial Performance
- 13.14.3. Product Portfolio
- 13.14.4. Strategic Initiatives
- 13.15. Gaia AG
- 13.15.1. Company Overview
- 13.15.2. Financial Performance
- 13.15.3. Product Portfolio
- 13.15.4. Strategic Initiatives
- 13.16. Limbix Health, Inc.
- 13.16.1. Company Overview
- 13.16.2. Financial Performance
- 13.16.3. Product Portfolio
- 13.16.4. Strategic Initiatives
- 13.17. Other Notable Players
- 13.17.1. Company Overview
- 13.17.2. Financial Performance
- 13.17.3. Product Portfolio
- 13.17.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 2 Global Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 3 Global Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 4 Global Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 5 Global Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 6 Global Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 7 North America Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 8 North America Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 9 North America Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 10 North America Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 11 North America Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 12 North America Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 13 U.S. Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 14 U.S. Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 15 U.S. Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 16 U.S. Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 17 U.S. Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 18 U.S. Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 19 Canada Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 20 Canada Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 21 Canada Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 22 Canada Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 23 Canada Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 24 Canada Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 25 Rest of North America Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 26 Rest of North America Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 27 Rest of North America Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 28 Rest of North America Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 29 Rest of North America Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 30 Rest of North America Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 31 UK and European Union Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 32 UK and European Union Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 33 UK and European Union Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 34 UK and European Union Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 35 UK and European Union Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 36 UK and European Union Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 37 UK Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 38 UK Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 39 UK Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 40 UK Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 41 UK Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 42 UK Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 43 Germany Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 44 Germany Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 45 Germany Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 46 Germany Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 47 Germany Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 48 Germany Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 49 Spain Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 50 Spain Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 51 Spain Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 52 Spain Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 53 Spain Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 54 Spain Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 55 Italy Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 56 Italy Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 57 Italy Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 58 Italy Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 59 Italy Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 60 Italy Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 61 France Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 62 France Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 63 France Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 64 France Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 65 France Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 66 France Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 67 Rest of Europe Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 68 Rest of Europe Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 69 Rest of Europe Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 70 Rest of Europe Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 71 Rest of Europe Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 72 Rest of Europe Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 73 Asia Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 74 Asia Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 75 Asia Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 76 Asia Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 77 Asia Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 78 Asia Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 79 China Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 80 China Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 81 China Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 82 China Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 83 China Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 84 China Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 85 Japan Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 86 Japan Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 87 Japan Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 88 Japan Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 89 Japan Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 90 Japan Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 91 India Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 92 India Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 93 India Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 94 India Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 95 India Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 96 India Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 97 Australia Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 98 Australia Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 99 Australia Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 100 Australia Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 101 Australia Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 102 Australia Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 103 South Korea Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 104 South Korea Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 105 South Korea Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 106 South Korea Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 107 South Korea Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 108 South Korea Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 109 Latin America Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 110 Latin America Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 111 Latin America Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 112 Latin America Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 113 Latin America Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 114 Latin America Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 115 Brazil Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 116 Brazil Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 117 Brazil Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 118 Brazil Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 119 Brazil Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 120 Brazil Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 121 Mexico Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 122 Mexico Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 123 Mexico Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 124 Mexico Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 125 Mexico Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 126 Mexico Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 127 Rest of Latin America Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 128 Rest of Latin America Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 129 Rest of Latin America Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 130 Rest of Latin America Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 131 Rest of Latin America Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 132 Rest of Latin America Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 133 Middle East and Africa Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 134 Middle East and Africa Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 135 Middle East and Africa Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 136 Middle East and Africa Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 137 Middle East and Africa Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 138 Middle East and Africa Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 139 GCC Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 140 GCC Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 141 GCC Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 142 GCC Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 143 GCC Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 144 GCC Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 145 Africa Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 146 Africa Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 147 Africa Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 148 Africa Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 149 Africa Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 150 Africa Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
- TABLE 151 Rest of Middle East and Africa Digital Therapeutics Market By Application, 2022-2032, USD (Million)
- TABLE 152 Rest of Middle East and Africa Digital Therapeutics Market By Preventive Applications, 2022-2032, USD (Million)
TABLE 153 Rest of Middle East and Africa Digital Therapeutics Market By Treatment/Care-related Applications, 2022-2032, USD (Million)
TABLE 154 Rest of Middle East and Africa Digital Therapeutics Market By CNS Disorders, 2022-2032, USD (Million)
TABLE 155 Rest of Middle East and Africa Digital Therapeutics Market By Sales Channel, 2022-2032, USD (Million)
- TABLE 156 Rest of Middle East and Africa Digital Therapeutics Market By End-Use, 2022-2032, USD (Million)
List of Figures
- FIG. 1 Global Digital Therapeutics Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Digital Therapeutics Market: Quality Assurance
- FIG. 5 Global Digital Therapeutics Market, By Application, 2023
- FIG. 6 Global Digital Therapeutics Market, By Sales Channel, 2023
- FIG. 7 Global Digital Therapeutics Market, By End-Use, 2023
- FIG. 8 Global Digital Therapeutics Market, By Geography, 2023
- FIG. 9 Market Geographical Opportunity Matrix - Global Digital Therapeutics Market, 2023
FIG. 10Market Positioning of Key Digital Therapeutics Market Players, 2023
FIG. 11Global Digital Therapeutics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
- FIG. 12 Global Digital Therapeutics Market, By Application, 2023 Vs 2032, %
- FIG. 13 Global Digital Therapeutics Market, By Sales Channel, 2023 Vs 2032, %
- FIG. 14 Global Digital Therapeutics Market, By End-Use, 2023 Vs 2032, %
- FIG. 15 U.S. Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 16 Canada Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 17 Rest of North America Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 18 UK Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 19 Germany Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 20 Spain Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 21 Italy Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 22 France Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 23 Rest of Europe Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 24 China Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 25 Japan Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 26 India Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 27 Australia Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 28 South Korea Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 29 Rest of Asia Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 30 Brazil Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 31 Mexico Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 32 Rest of Latin America Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 33 GCC Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 34 Africa Digital Therapeutics Market (US$ Million), 2022 - 2032
- FIG. 35 Rest of Middle East and Africa Digital Therapeutics Market (US$ Million), 2022 - 2032
